risks of taking bpc 157 in Australia: Benefits, side effects, and legality BPC-157 and Healing Peptides: Hype
Description
Take a few minutes
The April 2026 withdrawal of several peptides from Category 2, including BPC-157, TB-500, and MOTS-c, opens the door for future consideration
After an initial consultation and assessment, our medical professionals will prescribe Dihexa in either oral capsule form or topical cream
For where compounded GLP-1 access stands now, see our guide to semaglutide clinics and current sourcing, and for the affiliate and telehealth landscape, our peptide telehealth guide.
Wipe both stoppers with an alcohol swab
This is thanks to growing clinical evidence
